|
|
Aspergillus Enzyme May Point to Treatment for Gluten Intolerance
|
| Link ID |
2831 |
| Title |
Aspergillus Enzyme May Point to Treatment for Gluten Intolerance |
| Url |
http://www.medscape.com/viewarticle/569451?src=rss |
| Description |
A novel prolyl endoprotease from Aspergillus niger efficiently degrades gluten in a gastrointestinal model, according to a report in the January issue of Gut. If clinical trials bear out the findings, adding the enzyme to gluten-containing meals "might eliminate gluten toxicity, thus offering patients the possibility of abandoning (occasionally) their strict gluten-free diet," write the authors. Reuters Health Information |
| Category |
Articles > Gastroenterology |
| Keywords |
|
| Date |
Jan 31, 2008 |
| Contact Name |
|
| Email |
|
Write a Review
Add to My Favorite
Refer it to Friend
Report Broken Link
|
|
Other links at Articles > Gastroenterology |
| 4. |
Reversal of Fibrosis and Cirrhosis Seen With Long-Term Entecavir for Chronic HBV
|
|
|
Long-term treatment with the nucleoside analogue entecavir (Baraclude; Bristol-Myers Squibb) in patients with chronic hepatitis B virus (HBV) infection results in reversal of fibrosis and, in some milder cases, cirrhosis, investigators reported here at the annual meeting of the American Association of Liver Diseases. Reuters Health Information
|
|
|
